This reinforces the mechanistic distinction between direct antigen engagement of CD19 by the CAR under axi-cel, versus co-opting the endogenous immunity against tumor epitopes (dependent on antigen processing and presentation mechanisms25) under SOC. Here, CD19 is linked to neoplasm.